The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.

Brazilian Journal of Probability and Statistics, Vol. 27, No. 1 (February 2013), pp. 1-19 (19 pages) We introduce a Bayesian analysis for beta generalized distributions and related exponentiated ...

Empirical Bayes is a versatile approach to “learn from a lot” in two ways: first, from a large number of variables and, second, from a potentially large amount of prior information, for example, ...

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...